How does the body handle 4-Pro-MET? No direct human pharmacokinetic studies exist for this compound as of April 2026. But we can build a solid picture from its active metabolite 4-HO-MET and from structural analogues that have been well characterized. The estimated oral half-life sits around 2-4 hours, metabolism runs primarily through esterase-mediated hydrolysis in the liver, and researchers have identified at least 4 metabolites in urine so far.

4-Pro-MET is typically taken orally — pellets, drops, or powder. After ingestion, the compound dissolves in gastric fluid, crosses the intestinal wall, and enters the portal venous system before reaching systemic circulation. Gastric pH, stomach contents, and gut motility all shape how quickly this happens.

Here's where things get interesting. As an ester prodrug, 4-Pro-MET doesn't wait around. Carboxylesterase enzymes — CES1 in the liver, CES2 in the intestine — start hydrolyzing the propionyloxy group during absorption itself. So a fraction of every dose converts to 4-HO-MET before it even reaches the brain. The bioavailability of intact 4-Pro-MET is therefore well below 100%, and the ratio of prodrug to active metabolite in your bloodstream shifts continuously after dosing.

Estimated Absorption Parameters

Based on community reports and analogy to similar compounds, time to peak plasma concentration (Tmax) for 4-Pro-MET's active metabolite lands at roughly 1.5-3 hours post-oral administration. The compound ships as a fumarate salt, which dissolves readily in gastric fluid. No absolute oral bioavailability data exist. For comparison, psilocybin's oral bioavailability is estimated at approximately 50% with significant inter-individual variability.

Two stages. First, ester hydrolysis flips the prodrug into its active form. Then standard metabolic pathways break down 4-HO-MET for excretion.

Stage 1: Ester Hydrolysis (Prodrug Activation)

Carboxylesterases cleave the propionyloxy group, yielding 4-HO-MET and propanoic acid. This reaction fires primarily in the liver (CES1) and intestinal mucosa (CES2). How fast it happens depends on enzyme expression levels, which vary with age, genetics, and liver function. And because the propionyloxy ester carries more steric bulk than the acetyloxy ester in 4-AcO-MET — that extra carbon in the three-carbon chain — it's predicted to hydrolyze somewhat more slowly.

Stage 2: 4-HO-MET Metabolism

In vitro studies using human liver microsomes have identified 12 metabolites of 4-HO-MET, published in Forensic Science International (2018). The primary pathways:

• O-Glucuronidation: The 4-hydroxy group gets conjugated with glucuronic acid by UDP-glucuronosyltransferases (UGTs), producing a water-soluble metabolite ready for renal excretion
• N-Dealkylation: Cytochrome P450 enzymes (likely CYP2D6 and CYP3A4) strip methyl or ethyl groups from the nitrogen
• Oxidative deamination: MAO enzymes (primarily MAO-A) oxidize the amine side chain, generating an aldehyde intermediate
• Hydroxylation: Additional hydroxyl groups may be added to the indole ring system

Four of these metabolites have been confirmed in human urine samples. A non-fatal clinical case documented a 4-HO-MET plasma concentration of 193 ng/mL — clear evidence that the metabolite reaches blood levels consistent with an active pharmacological dose.

Metabolites leave the body mainly through the kidneys. The glucuronide conjugates of 4-HO-MET dissolve in water and get filtered by the glomeruli into urine. Based on analogy to psilocin and related tryptamines, estimated detection windows look like this:

• Blood/Serum: Few hours to 1-2 days (estimated)
• Urine (metabolites): 1-3 days (estimated)
• Hair: Theoretically detectable for months, but no validated analytical methods exist for 4-Pro-MET or 4-HO-MET in hair matrix

Standard immunoassay drug tests — the common urine strips — won't pick up 4-Pro-MET or its metabolites. You'd need LC-MS/MS (liquid chromatography-tandem mass spectrometry), equipment typically found only in forensic and clinical toxicology labs.